Why the study?
Are serum B-type natriuretic peptide (BNP) levels associated with anthracycline-induced cardiotoxicity?
Population
8 case-control studies pooling 126 patients with anthracycline-induced cardiotoxicity and 569 healthy controls
Comparison
Measurement of serum B-type natriuretic peptide… vs Healthy controls
Design
Meta-analysis
Authors
Loading...
Supports BNP monitoring for early anthracycline cardiotoxicity detection; confirms association yet low-certainty evidence leaves practice change open.
Are serum B-type natriuretic peptide (BNP) levels associated with anthracycline-induced cardiotoxicity?
Serum BNP levels are significantly elevated in patients with anthracycline-induced cardiotoxicity, supporting its potential utility as a biomarker for early detection.
WANG et al. (2016) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: